John Nuss, Chief Scientific Officer at Ventyx Biosciences, Inc. (VTYX), sold 27,624 shares at $31.61 ($873K) on 2022-12-22, disclosed to the SEC on 2022-12-23.
Open-market sale of $873k VTYX by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $31.61 | 13,812 | $437K | 50.0% |
| 2 | $31.61 | 13,812 | $437K | 50.0% |
| Total | $31.61 avg | 27,624 | $873K | 100% |
| Filing → |
| VTYX | SELL | 2024-12-30 | $50K | — | Filing → |
| VTYX | SELL | 2024-12-19 | $30K | — | Filing → |
| VTYX | SELL | 2024-04-03 | $9K | — | Filing → |